To determine whether the decreased viability of 2-APCAs-treated cancer cells was due to the activation of apoptosis as an outcome of mitotic arrest, we initially examined the expression of apoptotic markers (cleaved forms of caspase-3 and PARP). The gene discussed is CASP3; the disease is cancer.